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Studies of the model plant Arabidopsis thaliana may seem to have little impact on advances 
in medical research, yet a survey of the scientific literature shows that this is a misconception. 
Many discoveries with direct relevance to human health and disease have been elaborated 
using Arabidopsis, and several processes important to human biology are more easily studied 
in this versatile model plant.Arabidopsis thaliana, the reference spe-
cies for plant biology and a key model 
system for all of biology, has had a 
greater impact on human health research 
than may seem evident at first glance. In 
this Essay, we highlight examples where 
research using Arabidopsis has informed 
the identification of a prototype protein 
or domain involved in a human disease, 
human development, or other important 
aspects of human biology. These exam-
ples do not include the enormous impact 
that Arabidopsis research has had on 
plant biology, improving food secu-
rity, and alleviating malnutrition, which 
is a major threat to human health and 
is the basis of 50% of human disease 
worldwide. We make the case that well-
chosen, deep investment into research 
using plant genetic models will help to 
elucidate basic life processes and to illu-
minate the evolutionary plasticity of cel-
lular pathways and networks.
The Arabidopsis thaliana genome 
sequence was completed in 2000. Three 
years later, with the reporting of the 
annotated human genome sequence, it 
became evident that a majority of human 
genes that were suspected or known to 
play a role in disease had orthologs in 
Arabidopsis (http://mips.gsf.de/proj/thal/db/tables/disease.html). This marked 
degree of similarity in “disease genes” 
is comparable to that observed in other 
model organisms. For example, among 
cancer genes, 70% of genes implicated 
in cancer have Arabidopsis orthologs 
with E-value cutoffs of less than E^10, 
whereas the percentage of orthologs in 
the fruit fly Drosophila melanogaster is 
67%, in the worm Caenorhabditis ele-
gans is 72%, and in the budding yeast 
Saccharomyces cerevisiae is 41%. In one 
sense, this high percentage of shared 
genes is not surprising given that devel-
opment and disease follow the normal 
and abnormal activities, respectively, of 
proteins that serve basic cellular func-
tions. But with 1.6 billion years for Ara-
bidopsis and humans to have diverged, 
is it too much to expect that the original 
functions of these gene products sur-
vived intact? Are the distinct body plans 
and life strategies of humans and plants 
so different that the respective human 
and plant orthologs were not similarly 
constrained in their evolution and could 
not conceivably function in a similar 
way? We answer “no” to both questions 
by highlighting several examples where 
Arabidopsis research led the way in the 
discovery or analysis of genes and pro-Cell cesses of importance in human health. 
Many model systems greatly impacted 
human health, and we argue that Arabi-
dopsis is a part of this diversified portfo-
lio of tools needed to understand basic 
cellular processes.
Innate Immunity and Intracellular 
Receptors
Plant NB-LRR proteins (nucleotide-
binding site - leucine-rich repeats) are 
the primary intracellular receptors of the 
plant immune system and are encoded 
by what are historically termed disease 
resistance genes (Jones and Dangl, 
2006). The first plant NB-LRR genes 
were reported in 1994 and 1995. There 
are ~150 of these genes in Arabidopsis, 
and their definition enabled annotation 
of candidate disease resistance genes in 
many flowering plants. Equivalent human 
orthologous and paralogous genes in the 
animal innate immune system are vari-
ously called NOD/CARD/CATERPILLAR 
(Ting et al., 2006).
These proteins are involved in a vari-
ety of inflammatory responses. Most 
importantly, genetic variation in NOD2, 
cryopyrin, and CIITA (MHC class II trans-
activator) in humans and Naip5 (neuronal 
apoptosis inhibitory protein 5) in mice is 133, June 13, 2008 ©2008 Elsevier Inc. 939
associated with inflammatory disease 
or increased susceptibility to bacterial 
infections as well as cold-induced auto-
inflammatory syndrome and Mediter-
ranean fever. Mammalian NOD proteins 
may be cytosolic sensors for the induc-
tion of apoptosis, as well as for innate 
recognition of microorganisms and for 
regulation of inflammatory responses. 
The first human NOD gene, CIITA, was 
isolated in 2000 (Ting et al., 2006), and 
the connection was made to the NB-LRR 
plant disease resistance genes. NOD2 
was the first candidate gene cloned for 
Crohn’s disease, a severe inflammatory 
disorder of the small intestine (Hugot et 
al., 2001). This candidate gene was iden-
tified by virtue of its homology with the 
plant NB-LRR proteins.
The plant NB-LRR proteins are asso-
ciated with molecular chaperones that 
may be required to “hold and mold” 
them in a signal-competent manner. The 
involvement of the cytosolic HSP90 and 
SGT1 chaperone proteins in the immune 
response was first defined in plants, 
along with the plant-specific RAR1 pro-
tein, which is structurally related to ani-
mal p24 (Jones and Dangl, 2006). Animal 
orthologs of cytosolic HSP90 and SGT1 
were subsequently shown to control 
NOD/CATERPILLAR function in animal 
innate immunity (da Silva Correia et al., 
2007; Mayor et al., 2007). The NB-LRR 
and the NOD/CARD/CATERPILLAR 
proteins exist in a complex functional 
relationship with the Toll-like receptors 
(TLRs), which are pattern recognition 
receptors involved in detection of micro-
bial pathogens. A distinct set of extracel-
lular pattern recognition receptors oper-
ates in the plant innate immune system. 
These carry extracellular leucine-rich 
repeats but use cytosolic serine-threo-
nine kinase signaling domains instead of 
Toll/interleukin-1 receptor (TIR) domains. 
Several of these act like animal TLRs to 
recognize pathogen-associated molecu-
lar patterns (Zipfel et al., 2006).
Light Signaling, Protein 
 Degradation, and Cancer
Plants exhibit considerable pheno-
typic plasticity as most plant organs 
do not arise until after the seed germi-
nates, allowing organ size, shape, and 
physiology to be optimized to the local 
environment throughout their develop-940 Cell 133, June 13, 2008 ©2008 Elsevierment. Because they are sessile and 
photosynthetic, plants are especially 
attuned to their light environment. Light 
influences every developmental transi-
tion from seed germination to flower-
ing, with particularly dramatic effects on 
the morphogenesis of seedlings. Light 
signals do not act autonomously but 
are integrated with seasonal and diur-
nal changes in temperature, as well as 
with intrinsic developmental programs 
to specify correct spatial and temporal 
regulation of gene expression, organelle 
development, and cellular differentiation. 
The diverse responses that plants have 
to light provide a unique model system 
for understanding phenotypic plasticity. 
As a result, the study of light signaling in 
plants has not only provided insight into 
plant growth and development but also 
has led to the discovery of conserved 
proteins that regulate transcription, 
tumorigenesis, and lipid metabolism in 
metazoans (Yi and Deng, 2005).
Almost 20 years ago, mutant screens 
for dark-grown seedlings that resemble 
light-grown plants led to the discovery 
of a handful of genes, called DET, COP, 
and FUS, which based on genetic experi-
ments encode regulatory proteins that act 
downstream of multiple photoreceptors 
(Chory et al., 1989). Many of these genes 
were cloned by the early 1990s, and bio-
chemical studies revealed that most of 
these proteins played a role in targeted 
protein turnover. These proteins were 
found to be either part of an evolutionarily 
conserved protein complex of eight sub-
units (CSN1-8), called the COP9 signalo-
some after its prototype subunit COP9, 
or part of an E3 ligase called the CDD 
complex (COP10, DET1, DDB1) charac-
terized in both plants and animals (Wei 
and Deng, 2003; Yi and Deng, 2005). The 
CDD complex is now the most recently 
characterized E3 ligase and functions in 
the light-regulated development of plants. 
The best characterized activity of the 
CSN is its ability to cleave and remove the 
ubiquitin-like protein, Nedd8, from cullin 
ubiquitin ligase subunits (a process called 
denedyllation). Neddylation is another 
process that was elucidated first in Ara-
bidopsis (see below).
The discovery of light signaling path-
way components in plants, such as the 
COP1 E3 ligase, the COP9 signalosome, 
and DET1, boosted our understanding  Inc.of the effects on gene expression of the 
mammalian p53 tumor suppressor (Dor-
nan et al., 2004) and the transcription 
factors CREB (Qi et al., 2006) and c-JUN 
(Wertz et al., 2004). Understanding of 
these plant molecules also shed light on 
T cell homeostasis (Menon et al., 2007) 
and on fatty-acid synthetic enzymes in 
lipid metabolism in animals (Qi et al., 
2006). Detailed biochemical studies of 
the plant proteins revealed how turnover 
of the mammalian factors is regulated. 
Considerable work in plants elucidated 
the function of the COP9 signalosome 
and COP1, which facilitated research 
on these proteins in animal cells. Thus, 
studying light signaling in plants enabled 
new avenues of inquiry relevant to mam-
malian tumorigenesis, DNA damage, and 
lipid metabolism.
Cryptochromes and the Circadian 
Clock
After years searching for a blue-light 
photoreceptor in plants, Ahmad and 
Cashmore (1993) identified a gene that, 
upon careful scrutiny, encoded a protein 
that fit the bill. The name cryptochrome 
(CRY1) was given because many of the 
blue-light responses that were used his-
torically as diagnostics were found in 
cryptogams, an old term describing non-
flowering plants like ferns, mosses, and 
algae. Cryptochromes modulate devel-
opmental processes, such as flowering, 
that are under control of the photope-
riod. Many other blue-light responses 
in plants are regulated by another family 
of blue-light photoreceptors called phy-
totropins. Arabidopsis has two crypto-
chromes, CRY1 and CRY2, prototypes 
among members of the larger class 
found in eukaryotes, which evolved from 
DNA photolyases. Most plant crypto-
chromes contain an amino-terminal 
photolyase-like domain and a carboxy-
terminal domain, which are important 
for trafficking of molecules between the 
nucleus and cytosol. The carboxy-ter-
minal domain also forms protein-protein 
interfaces with other photoreceptors and 
with the protein degradation machinery 
(including COP1) to target specific tran-
scription factors (Li and Yang, 2007).
Among the many developmental 
phenomena that involve plant crypto-
chromes is circadian rhythm. Mamma-
lian CRY homologs were cloned in 1998 
by Aziz Sancar’s group (Thresher et al., 
1998). Loss of either the mouse CRY1 or 
CRY2 gene confers altered (and oppo-
site) free-running circadian periods. Loss 
of CRY2 attenuates the light induction of 
the Per gene, which encodes a compo-
nent of the circadian clock (Thresher et 
al., 1998). CRY1 and CRY2 along with the 
proteins PER1 and PER2 form the core 
of the mammalian clock. CRY is targeted 
for degradation by an F box protein of an 
E3 ubiquitin ligase and mutations in this 
F box protein extend the circadian period 
in mice (Virshup and Forger, 2007). These 
contributions and other work using the 
Drosophila CRY and Per gene homologs 
led to the conclusion that cryptochromes 
entrain the circadian clock by interacting 
with some of the clock components.
It may not be surprising then that a 
number of diseases that depend on a 
functioning circadian clock are sus-
pected to be caused by defects in the 
cryptochrome pathway. For example, 
altered circadian rhythm is associated 
with some cancers, although the jury is 
still out on whether the circadian defects 
are causative.
AXR1, The Ubiquitin Cycle, and 
Alzheimer’s Disease
Auxins are low molecular weight plant 
hormones that regulate virtually all 
aspects of plant development through 
effects on cell division, elongation, and 
differentiation. Genetic and biochemical 
studies in Arabidopsis showed that auxin 
regulates gene expression by promoting 
the ubiquitin-dependent degradation of 
transcriptional repressors called Aux/
IAA proteins (Parry and Estelle, 2006). 
Because the ubiquitin pathway is highly 
conserved among eukaryotes, several 
discoveries in auxin research had impor-
tant implications for cellular regulation 
in animals. The first Arabidopsis pro-
tein shown to be required for an auxin 
response was AXR1 (Parry and Estelle, 
2006). Working simultaneously in both 
Arabidopsis and yeast, researchers in 
the Estelle lab demonstrated that AXR1 
is required for conjugation of a ubiquitin-
related protein called RUB1 onto CUL1, 
a subunit of a ubiquitin protein ligase 
(E3 type) called SCF (Parry and Estelle, 
2006). Genetic studies in Arabidopsis 
indicate that RUB1 modification of CUL1 
is essential for SCF activity. One such E3 ligase, SCFTIR1, targets the Aux/IAAs 
for degradation (Kepinski, 2007). Subse-
quent studies in animal systems demon-
strated that the animal ortholog of RUB1, 
Nedd8, is also required for SCF function 
and that the RUB1/Nedd8 conjugation 
pathway is conserved between plants 
and animals (Petroski and Deshaies, 
2005). SCFs are involved in many 
aspects of cell growth in animals and are 
implicated in human diseases including 
cancer (Petroski and Deshaies, 2005). 
In addition, altered cullin neddylation 
is associated with Alzheimer’s disease. 
For example, the human protein APP-
AB1 binds to amyloid precursor protein 
(APP), the source of β-amyloid plaques 
that accumulate in the brains of patients 
with Alzheimer’s disease (Chow et al., 
1996). The significance of this interac-
tion is not completely clear, but recent 
evidence in Drosophila suggests that 
APP binding to APP-AB1 reduces cullin 
neddylation, thus potentially altering the 
activity of many different SCFs (Chow et 
al., 1996; Kim et al., 2007a).
Given that activity of the ubiquitin path-
way, and SCFs in particular, has such an 
important role in human disease, there 
has been extensive research on regula-
tion of SCF-substrate interactions. For 
many SCFs, phosphorylation of the sub-
strate is required for binding (Petroski 
and Deshaies, 2005). However, in the 
case of SCFTIR1, substrate recognition 
is governed by binding of auxin directly 
to the F box protein subunit of the SCF 
(Kepinski, 2007). In a sense, auxin may 
act like “molecular glue,” stabilizing an 
interaction between these two proteins. 
Thus, work in Arabidopsis introduced 
an entirely new way of regulating pro-
tein-protein interactions. At this point it 
is not known if animals use this type of 
regulation, but given the conservation of 
fundamental biochemical processes, it 
certainly seems likely.
Argonautes and RNA Silencing
A variety of small regulatory RNAs 
including small-interfering RNAs (siR-
NAs), microRNAs (miRNAs), transacting 
siRNAs (tasiRNAs), and Piwi-interacting 
RNAs (piRNAs) are major regulators of 
myriad processes in eukaryotic cells 
through silencing different classes of 
genes (Chapman and Carrington, 2007). 
For example, more than a third of human Cell protein-coding RNAs appear to be tar-
gets of different microRNAs. The Argo-
naute proteins, which serve as catalytic 
components of the RNA-induced silenc-
ing complex, are key regulators of these 
various RNA-silencing processes and 
interact directly with the relevant small 
RNA to help guide it to its target mRNA. 
Plant research has made a major impact 
on the field of RNA silencing. Some of the 
first descriptions of homology-depen-
dent gene silencing phenomena, such 
as cosuppression and RNA-directed 
DNA methylation, and the discovery of 
siRNAs and of the enzyme Dicer were 
made in plants (Matzke et al., 2001). In 
addition, the first Argonaute gene was 
cloned from Arabidopsis.
The implications for Argonaute proteins 
and RNA silencing in human health and 
disease are immense. First and foremost, 
RNA interference (RNAi) may hold prom-
ise for treating a diverse array of human 
diseases including age-related macular 
degeneration, Alzheimer’s disease, and 
arthritis (Kim and Rossi, 2007). RNAi is 
under development for downregulating 
viruses such as the hepatitis B virus, HIV, 
and respiratory syncytial virus, as well as 
oncogenes important in tumorigenesis. 
RNAi has proved invaluable for studying 
the loss of gene function in mammalian 
systems, speeding along basic research 
and allowing the rapid development of 
animal models in which disease genes 
are silenced by RNAi (Kim and Rossi, 
2007). Finally, misregulation of microR-
NAs is associated with a variety of clini-
cally important diseases and cancers, 
and Argonaute proteins themselves have 
been linked to disorders such as fragile 
X syndrome and some forms of autoim-
mune disease.
DNA Methylation
Cytosine DNA methylation is an epi-
genetic mark for gene silencing that 
is important in many gene regulatory 
systems including genomic imprint-
ing, X chromosome inactivation, and 
the silencing of transposons and other 
DNA sequences containing either direct 
or inverted repeats. Despite the impor-
tance of DNA methylation and decades 
of phenomenological descriptions of 
epigenetic regulatory systems (Chan et 
al., 2005; Goll and Bestor, 2005), genetic 
studies of the mechanisms regulating 133, June 13, 2008 ©2008 Elsevier Inc. 941
DNA methylation are still underdevel-
oped. In part, this reflects the fact that 
although methylation is present in most 
eukaryotes, it was curiously lost in sev-
eral well-studied model organisms such 
as baker’s yeast and C. elegans. Ara-
bidopsis is arguably one of the best 
organisms for genetic studies of DNA 
methylation because it has much in 
common with mammalian systems, hav-
ing orthologs of the two major human 
DNA methyltransferases, Dnmt1 and 
Dnmt3. Furthermore, unlike the mouse 
where DNA methylation mutants are not 
viable, Arabidopsis tolerates mutations 
that virtually eliminate methylation, thus 
allowing detailed genetic analyses (Chan 
et al., 2005).
Several discoveries concerning DNA 
methylation were made first in Arabidop-
sis and were later translated to mam-
malian systems. For instance, the chro-
matin remodeling factor DECREASE IN 
DNA METHYLATION 1 (DDM1) was first 
discovered in screens for Arabidopsis 
mutants with loss of centromeric methy-
lation (Chan et al., 2005; Goll and Bestor, 
2005). Only later was the mammalian 
ortholog LSH shown to have the same 
effect. A second example is the rela-
tionship between histone methylation 
and DNA methylation, which was initially 
described in fungi and Arabidopsis and 
only subsequently in mammalian sys-
tems (Chan et al., 2005; Goll and Bestor, 
2005). A third example is the function of 
an accessory factor for Dnmt1, UHRF1. 
Its ortholog, VIM1/ORTH2 was first 
shown in plant systems to be required 
for the maintenance of CG DNA methy-
lation. A key domain in this protein, the 
SRA domain, binds directly to methy-
lated DNA, giving clues to its mechanism 
of action. These early findings paved the 
way for functional studies of mouse and 
human UHRF1 showing it to be a critical 
cofactor that binds to hemimethylated 
DNA and directly recruits the mainte-
nance DNA methyltransferase Dnmt1 
(Ooi and Bestor, 2008).
Evidence for a role of DNA methy-
lation in human health and disease is 
overwhelming. Mutations in the human 
DNA methyltransferase gene Dnmt3b 
are the cause of ICF syndrome (immuno-
deficiency, centromeric instability, and 
facial anomalies), and mutations affect-
ing the methyl DNA-binding domain 942 Cell 133, June 13, 2008 ©2008 Elsevierprotein MeCP2 cause Rett syndrome, a 
childhood neurodevelopmental disorder 
(Goll and Bestor, 2005). Furthermore, it is 
increasingly clear that epigenetic muta-
tions, in the form of heritable hypermeth-
ylation or hypomethylation of particular 
tumor suppressor genes or oncogenes, 
are a major contributor to cancer (Jones 
and Baylin, 2007).
Leucine-Rich Receptor Kinases, Ion 
Transport, and G Protein Signaling
Studies of Arabidopsis also changed 
the direction of mammalian research 
in other ways, even when the proto-
type gene for a particular function or 
process may have been observed first 
in another model system. For example, 
the finding of Shaker-like potassium 
channels in Arabidopsis (Rodriguez-
Navarro and Rubio, 2006) advanced 
research into potassium fluxes in renal 
(Wang, 2004) and heart (Schwartz, 
2005) disease. The discovery of nitrate 
transporters in Arabidopsis (Tsay et 
al., 1993) led to the identification of 
peptide transporters in yeast and 
mammals. Leucine-rich serine/threo-
nine kinase receptors were first dis-
covered in Arabidopsis (Chang et al., 
1992). One member of the leucine-rich 
receptor kinase subfamily identified in 
humans, LRRK2, is genetically associ-
ated with Parkinson’s disease (Mata et 
al., 2006).
Considering the maturity of the field 
of heterotrimeric G protein signaling, it is 
hard to imagine how another model sys-
tem could make an impact, but break-
throughs in G protein research in Ara-
bidopsis have done just that. No other 
multicellular model system has a G pro-
tein repertoire as simple as that of Arabi-
dopsis (Temple and Jones, 2007). Plants 
and animals diverged from an ancestral 
cell 1.6 billion years ago, suggesting 
that much can be learned from studying 
the similarities and differences in their 
molecular properties (Johnston et al., 
2007). Indeed, comparative genomic and 
proteomic studies have opened up new 
research avenues. An excellent example 
is the comparison of the proteomic pro-
files of Arabidopsis (which does not have 
centrioles) and the single-celled alga 
Chlamydomonas (which does), yield-
ing several new basal body proteins in 
humans (Li et al., 2004). Inc.Natural Genetic Variation
The main focus of human genetics is cur-
rently the role that heritable differences 
play in disease susceptibility and the 
response to drugs. For natural genetic 
variation, Arabidopsis is arguably the 
best model organism available. The spe-
cies grows naturally under a wide range 
of environmental conditions through-
out much of the Northern hemisphere. 
Because it is self-fertile, locally adapted 
lines collected from the wild are naturally 
inbred. This in turn enables repeated phe-
notyping of the same genotypes under 
diverse controlled conditions, making 
Arabidopsis extremely well suited for 
studying genotype-environment interac-
tions, a problem of direct importance to 
the human genetics community.
Natural alleles that affect performance 
in the wild have been identified for many 
traits, a prominent example being the 
FRIGIDA gene controlling flowering 
(Johanson et al., 2000). An important 
question, which was central for design-
ing human association mapping studies, 
is whether common genetic syndromes 
are caused by just a few high-frequency 
alleles or by many rare alleles. Arabidop-
sis provides examples of both—indeed, 
the FRIGIDA work nicely showed that 
common and rare alleles with the same 
phenotypic effect can be found at the 
same locus.
The self-fertilizing habit of Arabidop-
sis makes genome-wide association 
studies extremely cost effective. Unlike 
human case-control studies, it is pos-
sible to genotype once and then phe-
notype many times under a huge variety 
of conditions. Arabidopsis now has a 
larger genomic polymorphism data-
base than any other nonhuman organ-
ism. For example, a 250,000 SNP-chip 
for genome-wide association studies is 
currently being used to genotype over 
1,000 wild strains (Kim et al., 2007b) 
(http://walnut.usc.edu/2010). Given 
that the extent of linkage disequilib-
rium is comparable to that in humans, 
coverage of the genome is likely better 
for Arabidopsis because of its smaller 
genome. Similarly, filling in between the 
HapMap tag-SNPs will be much more 
straightforward, and efforts to accom-
plish this are under way. The genetic 
variation resource can be easily comple-
mented by whole-genome epigenomic 
 information. Arabidopsis is thus likely to 
lead the way in the endeavor to produc-
tively combine the most important cur-
rent trends in medical research: genetic 
diversity and systems biology.
Diversifying Our Portfolio
In addition to the discoveries described 
here, it is worth mentioning some of the 
earlier examples of fundamental findings 
made first in plants that have turned out to 
be critical for our understanding of human 
biology: cells, nuclei, genes, molecular 
chaperones, viruses, transposable ele-
ments, programmed cell death, and gas-
eous hormones. As the predominant plant 
model system, Arabidopsis has followed 
in this tradition. It has proven to be the 
reference plant for translational work on 
agricultural improvements, and even as a 
relative newcomer on the “genetic model” 
block, it has shown its mettle in eukary-
otic research, with clear examples of 
how Arabidopsis research has impacted 
human health. The trend will continue, 
and we expect that soon Arabidopsis will 
be universally recognized and appreci-
ated as part of the diverse portfolio used 
in human health research.
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